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Alzheimer's disease (AD), a progressive neurodegenerative disease characterized by plaque buildup
in the brain, is one of the leading causes of death in older Americans. Many risk factor genes have
been proposed, but  relationships among them are not well understood. In this study, we focus on
the genetic risk factors Apolipoprotein E (APOE), Amyloid Precursor Protein (APP), and Presenilin 1
and 2 (PSEN1 and PSEN2). APOE has been considered the greatest genetic risk factor for AD. It is
believed that the characteristic amyloid beta plaques in the AD brain are a result of the cleaving of
APP by y-secretase, which is encoded by PSEN1 and PSEN2. Older adults and females have an
increased risk for AD.  The hippocampus is the most severely affected brain region in AD, so we
focused on the gene expression profile of the hippocampus compared to other brain regions. This
project aims to use Bayesian Networks to model the relationships and patterns of major genetic and
clinical  AD  risk  factors  with  brain  microarray  datasets  available  on  the  National  Center  for
Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database. A Bayesian Network
model incorperating background knowledge of AD risk factor relationships was compared to a model
derived from our data. The background knowledge model scored just as well or better than the
model  derived from our  data.  These models  indicated that  increased expression of  APOE and
decreased expression of APP, PSEN1, and PSEN2 are linked with increased AD risk. Female and
hippocampal samples tend to have greater dysregulated gene expressions compared to males and
non-hippocampal  regions.  Further  analysis  on  these  models  and  relationships  is  required,  but
elucidating the patterns of the risk factors highlighted here allow future research to build and
include other clinical and genomic risk factors that may improve understanding and treatment of
AD.
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